ANAPTYSBIO, INC. Shares Outstanding (Cover Page)
ANAPTYSBIO, INC. (ANAB) had Shares Outstanding (Cover Page) of 29.90 million shares as of 2026-09-16, per its 10-KT filed 2026-09-21.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-09-21
- 2026-09-16: Entity Common Stock, Shares Outstanding 29.90M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 29.10M shares.
- 2026-04-23: Entity Common Stock, Shares Outstanding 29.10M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 28.75M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-09-16 | 29.90M shares 10-KT · filed 2026-09-21 |
| 2026-05-07 | 29.10M shares 10-Q · filed 2026-05-12 |
| 2026-04-23 | 29.10M shares 10-K/A · filed 2026-04-28 |
| 2026-02-27 | 28.75M shares 10-K · filed 2026-03-03 |
| 2025-10-30 | 27.69M shares 10-Q · filed 2025-11-04 |
| 2025-08-01 | 28.00M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 29.38M shares 10-Q · filed 2025-05-05 |
| 2025-02-24 | 30.67M shares 10-K · filed 2025-02-27 |
| 2024-10-31 | 30.43M shares 10-Q · filed 2024-11-05 |
| 2024-07-31 | 27.45M shares 10-Q · filed 2024-08-05 |
| 2024-05-06 | 27.32M shares 10-Q · filed 2024-05-09 |
| 2024-03-05 | 26.76M shares 10-K · filed 2024-03-11 |
| 2023-10-30 | 26.58M shares 10-Q · filed 2023-11-02 |
| 2023-08-02 | 26.55M shares 10-Q · filed 2023-08-07 |
| 2023-05-09 | 26.49M shares 10-Q · filed 2023-05-11 |
| 2023-02-27 | 27.93M shares 10-K · filed 2023-03-01 |
| 2022-11-04 | 28.43M shares 10-Q · filed 2022-11-08 |
| 2022-08-04 | 28.24M shares 10-Q · filed 2022-08-08 |
| 2022-05-02 | 28.19M shares 10-Q · filed 2022-05-04 |
| 2022-03-03 | 27.67M shares 10-K · filed 2022-03-07 |
| 2021-11-02 | 27.51M shares 10-Q · filed 2021-11-04 |
| 2021-08-05 | 27.43M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 27.37M shares 10-Q · filed 2021-05-04 |
| 2021-02-23 | 27.37M shares 10-K · filed 2021-02-25 |
| 2020-11-02 | 27.35M shares 10-Q · filed 2020-11-04 |
| 2020-08-06 | 27.30M shares 10-Q · filed 2020-08-10 |
| 2020-05-04 | 27.28M shares 10-Q · filed 2020-05-06 |
| 2020-02-27 | 27.27M shares 10-K · filed 2020-03-02 |
| 2019-11-05 | 27.13M shares 10-Q · filed 2019-11-08 |
| 2019-08-05 | 27.05M shares 10-Q · filed 2019-08-08 |
| 2019-05-03 | 27.02M shares 10-Q · filed 2019-05-07 |
| 2019-02-25 | 26.99M shares 10-K · filed 2019-02-28 |
| 2018-11-06 | 26.75M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 24.04M shares 10-Q · filed 2018-08-07 |
| 2018-05-04 | 23.50M shares 10-Q · filed 2018-05-08 |
| 2018-02-28 | 23.81M shares 10-K · filed 2018-03-05 |
| 2017-11-03 | 23.50M shares 10-Q · filed 2017-11-07 |
| 2017-08-08 | 20.34M shares 10-Q · filed 2017-08-10 |
| 2017-05-09 | 20.27M shares 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |